Key result
Thrombolytic therapy is effective in acute myocardial infarction, with tissue plasminogen activator offering benefits over streptokinase when administered within 4 hours of presentation.
Why the study?
Does thrombolytic and antithrombotic therapy improve outcomes in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction (MI)
Design
Review
Authors
Loading...
Supports early thrombolysis in AMI; leaves open optimization versus primary PCI in contemporary practice.
Does thrombolytic and antithrombotic therapy improve outcomes in patients with acute myocardial infarction?
This review outlines the principles and guidelines for using thrombolytic and antithrombotic therapies in acute myocardial infarction, emphasizing early administration and appropriate adjunctive treatments.
Jafri et al. (1995) conducted a review in Acute myocardial infarction. Thrombolytic and antithrombotic therapy was evaluated. Thrombolytic therapy is effective in acute myocardial infarction, with tissue plasminogen activator offering benefits over streptokinase when administered within 4 hours of presentation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: